Дело T-***/**: *****************, Съдебно решение от **.**.2021 г.

Текст

In Case T‑397/20,

Allergan Holdings France SAS, established in Courbevoie (France), represented by J. Day, Solicitor, and T. de Haan, lawyer,

applicant,

v

European Union Intellectual Property Office (EUIPO), represented by K. Zajfert and V.J. Ruzek, acting as Agents,

defendant,

the other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court, being

Dermavita Company S.a.r.l., established in Beirut (Lebanon), represented by D. Todorov, lawyer,

ACTION brought against the decision of the Fourth Board of Appeal of EUIPO of 14 April 2020 (Case R 877/2019‑4), relating to revocation proceedings between Dermavita Company and Allergan Holdings France,

THE GENERAL COURT (Third Chamber),

composed of A.M. Collins, President, V. Kreuschitz and Z. Csehi (Rapporteur), Judges,

Registrar: A. Juhász-Tóth, Administrator,

having regard to the application lodged at the Court Registry on 26 June 2020,

having regard to the response of EUIPO lodged at the Court Registry on 16 September 2020,

having regard to the response of the intervener lodged at the Court Registry on 21 September 2020,

having regard to the plea of inadmissibility raised by the intervener by document lodged at the Court Registry on 21 September 2020,

having regard to the applicant’s observations on the plea of inadmissibility, lodged at the Court Registry on 20 November 2020,

having regard to the order of 18 December 2020 reserving the decision on the plea of ...